Biodegradable Dendronized Polymer Vectors for RNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for delivering messenger RNA (mRNA) and single-stranded RNA (ssRNA) into cells face challenges due to instability, immunogenicity, and inefficient delivery, particularly for therapeutic applications like cancer treatment and stem-cell therapy, where mRNA needs to be targeted to the cytoplasm without integrating into chromosomes or causing mutagenesis.
Innovation Solution
Development of biodegradable dendronized polymer vectors that form stable complexes with mRNA and ssRNA, incorporating histidine and tryptophan moieties and polyoxyalkylene polymers, allowing for effective delivery by preventing aggregation and enhancing cellular uptake, and enabling targeted delivery to specific cells such as cancer cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If mRNA is delivered using conventional methods (liposomes, cationic polymers), then delivery efficiency to cytoplasm is improved, but immunogenicity and instability increase
Solution Approach 1:
The patent modifies the chemical structure of polymer vectors by incorporating biodegradable blocks (PLA, PLGA) with specific molecular weights and compositions. By adjusting parameters such as lactide:glycolide ratio, molecular weight, and block copolymer architecture, the vectors achieve optimal balance between delivery efficiency and reduced immunogenicity while maintaining stability
Solution Approach 2:
The invention uses composite polymer structures combining biodegradable blocks (PLA/PLGA) with functional blocks designed for mRNA complexation. These composite materials integrate multiple functions: protection of mRNA, controlled degradation, and reduced immune recognition, simultaneously improving delivery efficiency while minimizing harmful effects
2Reliability
If mRNA is delivered using viral vectors or plasmid DNA, then protein expression is achieved, but risks of insertive mutagenesis and chromosomal integration occur
Solution Approach 1:
The patent extracts only the essential function of genetic material delivery (protein expression) while removing the harmful integrating components. By using mRNA instead of DNA and biodegradable polymer vectors instead of viral vectors, the system achieves protein expression without chromosomal integration or insertive mutagenesis
Solution Approach 2:
The invention employs transient mRNA molecules delivered by biodegradable polymers that degrade after delivering their payload. This disposable approach achieves reliable protein expression temporarily without permanent genetic modification, eliminating mutagenesis risks associated with integrating vectors
3Productivity
If synthetic vectors are used for mRNA delivery, then delivery to cytoplasm is effective, but the vectors are understudied and lack optimization compared to siRNA and pDNA methods
Solution Approach 1:
The patent performs preliminary optimization of polymer vector structures before clinical application. By systematically studying biodegradable polymer compositions, molecular weights, and architectures in advance, the invention establishes optimized formulations that achieve effective mRNA delivery, addressing the lack of prior optimization
Solution Approach 2:
The invention systematically varies and optimizes multiple parameters including polymer molecular weight, lactide:glycolide ratio, block copolymer architecture, and formulation conditions. This comprehensive parameter optimization matures the synthetic vector technology, making it as well-characterized as established siRNA and pDNA methods
4Device complexity
If mRNA is delivered without protective vectors, then simplicity is maintained, but enzymatic degradation and instability occur
Solution Approach 1:
The patent uses biodegradable polymer vectors that form protective complexes around mRNA molecules. These flexible polymer shells protect the mRNA from enzymatic degradation while allowing controlled degradation of the vector itself, maintaining both protection and simplicity
Solution Approach 2:
The invention employs biodegradable polymers that are deliberately designed to degrade after delivering their mRNA payload. The temporary protective structure is discarded through controlled degradation, maintaining simplicity while providing necessary stability during the critical delivery period
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The dendronized polymer vectors ensure efficient and stable delivery of mRNA and ssRNA into cells, reducing immunogenicity and enzymatic degradation, and promoting therapeutic antitumor immunity and genome editing capabilities, while avoiding the risks of chromosomal integration and mutagenesis.
Implementation Method 1
the vectors disclosed herein are capable of forming stable and favorable complexes with mRNA and/or ssRNA without forming aggregates
Data Source
AI summary
The disclosure provides for vectors, and methods of using the vectors to efficiently deliver mRNA and/or ssRNA into cells.